subscribeSubscribe
FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV

FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV
BUSINESSWIRE
26 Apr 2024
Share Share
Gilead Sciences Announces First Quarter 2024 Financial Results

Gilead Sciences Announces First Quarter 2024 Financial Results
PRESS RELEASE
26 Apr 2024
Share Share
Laurus Labs` Generic Bictegravir, Emtricitabine, Tenofovir Alafenamide Receives Approval in the U.S.

Laurus Labs` Generic Bictegravir, Emtricitabine, Tenofovir Alafenamide Receives Approval in the U.S.
FDA
02 Feb 2024
Share Share
FDA Confirms Paragraph IV Patent Litigation for Bictegravir Sodium, Emtricitabine and Tenofovir Alafenamide Fumarate Tablets

FDA Confirms Paragraph IV Patent Litigation for Bictegravir Sodium, Emtricitabine and Tenofovir Alafenamide Fumarate Tablets
FDA
20 Nov 2023
Share Share
Gilead Wins HIV Patent Suit, Nabs Oncology and Inflammation Startup

Gilead Wins HIV Patent Suit, Nabs Oncology and Inflammation Startup
Tristan Manalac BIOSPACE
11 May 2023
Share Share
Gilead, US square off in billion-dollar HIV drug patent trial

Gilead, US square off in billion-dollar HIV drug patent trial
Blake Brittain REUTERS
03 May 2023
Share Share
ViiV, Gilead row escalates to feds after self-regulation fails

ViiV, Gilead row escalates to feds after self-regulation fails
Nick Paul Taylor FIERCE PHARMA
02 May 2023
Share Share
Aurobindo`s Generic Emtricitabine, Tenofovir Disoproxil Fumarate Receives Approval in the U.S.

Aurobindo`s Generic Emtricitabine, Tenofovir Disoproxil Fumarate Receives Approval in the U.S.
FDA
09 Mar 2023
Share Share
GSK`s ViiV says its long-acting HIV shot as effective as Gilead`s daily pill

GSK`s ViiV says its long-acting HIV shot as effective as Gilead`s daily pill
REUTERS
23 Feb 2023
Share Share
Lupin gets USFDA nod for Dolutegravir, Emtricitabine and Tenofovir tablets

Lupin gets USFDA nod for Dolutegravir, Emtricitabine and Tenofovir tablets
ECONOMIC TIMES
31 Jan 2023
Share Share